Team:EPF Lausanne/Project immuno

From 2010.igem.org

(Difference between revisions)
(P-proteins)
(B: The P-proteins are not expressed)
 
(156 intermediate revisions not shown)
Line 14: Line 14:
{{EPFL_2010_sub_menu_projects}}
{{EPFL_2010_sub_menu_projects}}
 +
<div CLASS="EPFL_content">
<div CLASS="EPFL_content">
-
= P-proteins =
+
=Proteins=
-
 
+
[[Image:P25_and_p28.png‎|right|150px|caption]]
-
The ookinete has been intensively studied by scientists, looking for an ideal transmission-blocking vaccine target. IGEM EPFL team is interested in ookinete surface membrane protein Pfs25 and Pfs28. In fact, it has been shown that the binding of specific antibodies to these surface proteins prevented the malaria transmission in more than 99% of the cases [1]. Indeed, P25 and P28 seem to be essential to the ookinete survival, the crossing of the midgut epithelium and its transformation into an oocyst.  
+
We have chosen two different ways to target the parasite <i>P.falciparum</i> and prevent the malaria transmission through mosquitos. Our engineered bacteria could express either an immunotoxin, or two "p-proteins", or even both for maximum efficiency. We tried to express all of these proteins using the C3 plasmid incorporating the [https://2010.igem.org/Image:EPFL_CFP_prom.png strong promoter], a constitutive sequence for greater level of expression.  
-
 
+
[[Image:Immuno.png‎|left|150px|caption]]
-
We decided to design Asaia to express a soluble form of these 2 P-proteins. It could seems contra-intuitive to provide more of these proteins (by expression in Asaia) that are very important for the parasite survival, migration, and development. But our hypothesis is that adding a lot of these proteins in a soluble form will compete with the parasite surface protein and prevent the interaction necessary to its transmission.
+
The [https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background Immunotoxin] is one of our tools to block transmission of malaria parasite in mosquitos. It is composed of two main parts : The first one is a single-chain antibody fragment (scFv) directed to Pbs2l, which is a surface membrane protein of <i>Plasmodium berghei</i>. The second part is a lytic peptide, Shiva-1, which acts by forming “pores” on the parasite’s membrane. The immunotoxin is supposed to specifically target and lyse the parasite.
-
Because the functions of P25 and P28 are redundant, both proteins need to be inhibited or outcompeted to efficiently block the malaria transmission.
+
-
 
+
-
 
+
-
== Reference: ==
+
-
*[http://www.nature.com/emboj/journal/v20/n15/full/7593895a.html 1. Ana M. Tomas, Gabriele Margos, Robert E. Sinden, ''P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions'', The EMBO Journal (2001)]
 
-
= Effector molecules =
+
[[Image:Immunotoxin.jpg|680px|thumb|bottom|The different domaines of the immunotoxin. For more details and the sequence see the [https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background background] section.]]
-
'' Gwen: je vais supprimer ca demain, personne n'y voit d'inconvénient? ''
 
-
=== Candidate effectors molecules to block malaria propagation ===
 
 +
[[Image:Wiktor1.png‎|left|250px|caption]]
-
*A lytic peptide called '''SB-37''' similar (in term of length and amino acids property) to Shiva-1 (the lytic peptide of our ordered immunotoxin) was used to kill P. falciparum in vitro [1]. SB-37 is a slightly modified version of a Cecropin, the Cecropin B [1], the sequence is in the paper [1].
+
In parallel to the immunotoxin we thought of a different way of blocking the <i>P.falciparum</i> by using 
 +
[https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background P25 and P28] which belong to a class of important proteins expressed on the membrane of the Plasmodium. We called them the "P-proteins". They are mainly expressed on the mosquito-stage of the parasite (ookinete).
 +
The Plasmodium normally uses these P-protein to interact with the epithelium in order to go through it.
 +
[[Image:Wiktor4.png‎|right|250px|caption]]
-
*'''Cecropins''' are  peptides derived from the insect immune defence (a giant moth). Cecropin A was expressed in a simbiont of the bug Rhodnius prolixus in order to  kill T. cruzi, a parasite that cause the  Chagas disease [2]. More recently, It was also expressed in the mosquito’s gut (transgenic mosquitoes) to prevent the propagation of the malaria [3] (See [http://www.anaspec.com/products/product.asp?id=30699 Sequence]). Because of its hight homology the cecropins A and B, cecropin D could also be used (sequence: [4]). There exists 6 cecropins : cecropin A, … , F.
 
-
*The '''Glossina attacin''' is an antimicrobial peptide effective on both gram-negative bacteria and protozoa (Plasmodium is a protozoa!). It was expressed in a symbiont of the tsetse fly in order to kill the pasasite T.brucei; We should determine if it acts on Asaia, attacins kill E.Coli but [http://www.copewithcytokines.org/cope.cgi?key=Attacins do not act on many other gram-positive and gram-negative bacteria]. Sequence: [5].
 
 +
Now if Asaia starts to produce a high amout of these proteins, the interactions will be disrupted and the plasmodium will not propagate through the mosquito's epithelium.
-
Other effectors molecules against Plasmodium are cited by Jacobs-Lorena and al. [6]:
 
-
*The '''salivary gland/midgut peptide (SM1)''', it is a dodecapeptide (sequence: [7]), It was found by testing a number of random peptides, and it binds to both the gut and salivary gland bocking the Plasmodium at these two stages.
 
-
*An other attractive approach is to block chitinase present in the mousquito’s gut. This enzyme plays an important role in modelling of the peritrofic matrix (PM, that surround the bood meal) which is an important barrier for the Plasmodium. It has been shown that inhibiting chitinase make the PM thicker and efficiently blocks the plasmodium development. Chitinase is activated by cleaving an N-terminal propeptide, and it has been demonstrated, by feeding the mosquito with the peptide, that this same propeptide, called '''prochitinase peptide''' (13 amino-acids) blocks efficiently the chinase activity and the plasmodium developement in the mosquito’s gut (sequence: [8]).
 
 +
=Results=
 +
==A: The Immunotoxin is expressed and appears in the supernatant==
 +
[[Image:EPFL Immuno growth.jpg|300px|thumb|right| <b>Growth curve of ''E. coli'' expressing the Immunotoxin:</b> In blue, we can see the growth curve of ''E. coli'' containing the empty C3 plasmid. In red, we can see the growth of ''E. coli'' transformed with the C3 plasmid containing the Immunotoxin sequence. We could conclude that the expression of the Immunotoxin in high concetrations may prevent ''E. coli'' from growing. ]]
 +
We tested expression of the immunotoxin in ''E. coli'' (see [https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Materials_Methods Materials and Methods] for details). In a western blot analysis of whole cell lysates we could see bands corresponding to full length immunotoxin and possibly degraded fragments of the protein (see gel image below).
-
*The Phospholypase A2 (PLA2) inhibits oocyst formation in the mousquito’s gut by feeding or expressing it in transgenic mousquitos (See [9] and [10]). Interestingly this enzyme comes from the snake or bee venom and its anti-malaria activity does not depend on its hydrolytic activity.
+
The immunotoxin contains a PelB sequence that targets it for secretion into the periplasm. We concentrated the supernatant of both the immunotoxin and a control culture by running it through a filtering device with a 5 kDa cut-off. Running a western blot with these samples (see gel image below) we verified that the immunotoxin was also found in the supernatant.  
 +
We observed that the cells containing the immunotoxin plasmid grew a lot slower than the control (see figure). This is probably due to the fact that the cells are producing the immunotoxin. Furthermore at high concentrations the immunotoxin might lyse the cells.
 +
 +
[[Image:EPFL Gel1 western.jpg|400px|thumb|center| <b>Gel1 (Lysates):</b> We can see distinct molecular fragments in the immunotoxin lane: The upper fragments (marked with red and purple arrows) match the molecular size of the immunotoxin of about 39 kDa. For the shorter of the two fragments the export tag pelB may have been cut off. The smaller sized fragment (green arrow) of about 20 kDa is most probably part of the degraded immunotoxin.
 +
<b>Gel2 (Supernatants):</b> A fragment of the correct size is detected in the supernatant. The smaller fragments (green and yellow arrows) probably correspond to smaller parts of the degraded immunotoxin. The band present in all lanes corresponds to a biotinylated protein which is detected by the secondary antibodies.]]
-
In summary we have those potential effector molecules:
+
==B: The P-proteins are not expressed ==
-
*SB-37
+
The same experiments were conducted for the p-proteins [https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background p25 and p28]. No bands were detected on the western blots (see figure) which leads us to the conclusion that these proteins were only very weakly expressed or not at all. This might be explained by the fact that we took the native sequence from <i>Plasmodium falciparum</i>. The genome of <i>Plasmodium falciparum</i> is very A-T-rich ([http://areslab.ucsc.edu/cgi-bin/hgGateway UCSC Malaria Genome Browser]).
-
*Ceropins (mainly A, B and D)
+
-
*Glossina attacin
+
-
*SM-1
+
-
*Prochitinase peptide
+
-
*PLA2
+
-
==References==
+
We think that expression of p25 and p28 may be improved by codon optimizing it for expression in bacteria like ''E. coli'' and ''Asaia'' as we did with the immunotoxin.
 +
Additional to the Western Blots, to rule out the possibility that concentration was too low, we attempted a protein purification (following the [http://openwetware.org/wiki/Knight:Purification_of_His-tagged_proteins/Denaturing Knight protocol]) from a large culture volume (see figure) using Ni-NTA columns.
-
*[http://www.ncbi.nlm.nih.gov/pubmed/3049204 1. Jaynes et al. 1988]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/9096383 2. Durvasula et al. 1997]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed 3. Kim et al. 2004]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/7140755 4. Hultmark et al. 1982]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/18477243 5. Wang et al., 2008]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/15894187 6. Jacobs-Lorena et al., 2005]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/11687659 7. Ghosh et al., 2001]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed 8. Bhatnagar et al., 2003]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/11809789 9. Zieler et al., 2001]
 
-
*[http://www.ncbi.nlm.nih.gov/pubmed/12167627 10. Moreira et al., 2002]
 
 +
[[Image:EPFL Silver stain wiki.jpg|700px|thumb|center| <b>Gel1 (Western Blot):</b> There are no fragments detected neither for p25 nor for p28. The fragment detected for the positive control around the weight expected verifies the success of the analysis.
 +
<b>Gel2 (Silver Stain):</b> We tried to purify the proteins in order to exclude the possibility that the proteins were not detected due to low concentration. Protein purification was followed by silver stain analysis. Again, no bands were detected on the gel.]]
 +
=References=
 +
*[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T29-42JHDJD-9&_user=10&_coverDate=03%2F31%2F2001&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5f4b78b08a1846e241faaed33bc76cb3&searchtype=a 1. Shigeto Yoshida, ''Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes'', Molecular and Biochemical Parasitology (2001)]
 +
*[http://www.nature.com/emboj/journal/v20/n15/full/7593895a.html 2. Ana M. Tomas, Gabriele Margos, Robert E. Sinden, ''P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions'', The EMBO Journal (2001)]
 +
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951121/?tool=pubmed 3. Ajay K. Saxena, Yimin Wu, and David N. Garboczi, ''Plasmodium P25 and P28 Surface Proteins: Potential Transmission-Blocking Vaccines'', Eukaryot Cell (2007)]
 +
*[http://www.nature.com/nsmb/journal/v13/n1/full/nsmb1024.html 4. Ajay et al., The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms, natures structural & molecular biology, 2005]
 +
{{EPFL_2010_bottom_wrap}}
</div>
</div>

Latest revision as of 00:50, 28 October 2010



Contents

Proteins

caption

We have chosen two different ways to target the parasite P.falciparum and prevent the malaria transmission through mosquitos. Our engineered bacteria could express either an immunotoxin, or two "p-proteins", or even both for maximum efficiency. We tried to express all of these proteins using the C3 plasmid incorporating the strong promoter, a constitutive sequence for greater level of expression.

caption

The Immunotoxin is one of our tools to block transmission of malaria parasite in mosquitos. It is composed of two main parts : The first one is a single-chain antibody fragment (scFv) directed to Pbs2l, which is a surface membrane protein of Plasmodium berghei. The second part is a lytic peptide, Shiva-1, which acts by forming “pores” on the parasite’s membrane. The immunotoxin is supposed to specifically target and lyse the parasite.


The different domaines of the immunotoxin. For more details and the sequence see the background section.


caption


In parallel to the immunotoxin we thought of a different way of blocking the P.falciparum by using P25 and P28 which belong to a class of important proteins expressed on the membrane of the Plasmodium. We called them the "P-proteins". They are mainly expressed on the mosquito-stage of the parasite (ookinete). The Plasmodium normally uses these P-protein to interact with the epithelium in order to go through it.

caption



Now if Asaia starts to produce a high amout of these proteins, the interactions will be disrupted and the plasmodium will not propagate through the mosquito's epithelium.




Results

A: The Immunotoxin is expressed and appears in the supernatant

Growth curve of E. coli expressing the Immunotoxin: In blue, we can see the growth curve of E. coli containing the empty C3 plasmid. In red, we can see the growth of E. coli transformed with the C3 plasmid containing the Immunotoxin sequence. We could conclude that the expression of the Immunotoxin in high concetrations may prevent E. coli from growing.

We tested expression of the immunotoxin in E. coli (see Materials and Methods for details). In a western blot analysis of whole cell lysates we could see bands corresponding to full length immunotoxin and possibly degraded fragments of the protein (see gel image below).

The immunotoxin contains a PelB sequence that targets it for secretion into the periplasm. We concentrated the supernatant of both the immunotoxin and a control culture by running it through a filtering device with a 5 kDa cut-off. Running a western blot with these samples (see gel image below) we verified that the immunotoxin was also found in the supernatant.

We observed that the cells containing the immunotoxin plasmid grew a lot slower than the control (see figure). This is probably due to the fact that the cells are producing the immunotoxin. Furthermore at high concentrations the immunotoxin might lyse the cells.

Gel1 (Lysates): We can see distinct molecular fragments in the immunotoxin lane: The upper fragments (marked with red and purple arrows) match the molecular size of the immunotoxin of about 39 kDa. For the shorter of the two fragments the export tag pelB may have been cut off. The smaller sized fragment (green arrow) of about 20 kDa is most probably part of the degraded immunotoxin. Gel2 (Supernatants): A fragment of the correct size is detected in the supernatant. The smaller fragments (green and yellow arrows) probably correspond to smaller parts of the degraded immunotoxin. The band present in all lanes corresponds to a biotinylated protein which is detected by the secondary antibodies.

B: The P-proteins are not expressed

The same experiments were conducted for the p-proteins p25 and p28. No bands were detected on the western blots (see figure) which leads us to the conclusion that these proteins were only very weakly expressed or not at all. This might be explained by the fact that we took the native sequence from Plasmodium falciparum. The genome of Plasmodium falciparum is very A-T-rich ([http://areslab.ucsc.edu/cgi-bin/hgGateway UCSC Malaria Genome Browser]).

We think that expression of p25 and p28 may be improved by codon optimizing it for expression in bacteria like E. coli and Asaia as we did with the immunotoxin. Additional to the Western Blots, to rule out the possibility that concentration was too low, we attempted a protein purification (following the [http://openwetware.org/wiki/Knight:Purification_of_His-tagged_proteins/Denaturing Knight protocol]) from a large culture volume (see figure) using Ni-NTA columns.


Gel1 (Western Blot): There are no fragments detected neither for p25 nor for p28. The fragment detected for the positive control around the weight expected verifies the success of the analysis. Gel2 (Silver Stain): We tried to purify the proteins in order to exclude the possibility that the proteins were not detected due to low concentration. Protein purification was followed by silver stain analysis. Again, no bands were detected on the gel.

References

  • [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T29-42JHDJD-9&_user=10&_coverDate=03%2F31%2F2001&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5f4b78b08a1846e241faaed33bc76cb3&searchtype=a 1. Shigeto Yoshida, Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes, Molecular and Biochemical Parasitology (2001)]
  • [http://www.nature.com/emboj/journal/v20/n15/full/7593895a.html 2. Ana M. Tomas, Gabriele Margos, Robert E. Sinden, P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions, The EMBO Journal (2001)]
  • [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951121/?tool=pubmed 3. Ajay K. Saxena, Yimin Wu, and David N. Garboczi, Plasmodium P25 and P28 Surface Proteins: Potential Transmission-Blocking Vaccines, Eukaryot Cell (2007)]
  • [http://www.nature.com/nsmb/journal/v13/n1/full/nsmb1024.html 4. Ajay et al., The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms, natures structural & molecular biology, 2005]

wrap bottom